We analysed the clinical symptoms and signs of pseudomyxoma peritonei (pmp), a rare syndrome affecting one to two persons per million annually. presumably, patients with pmp would benefit from early diagnosis. this study was conducted to further characterise the manifestations of pmp.
mucinous tumours coupled by mucinous ascites. The tumour spread throughout the peritoneal cavity slowly accumulates as the disease progresses, eventually resulting in symptoms of bowel obstruction, dyspnoea and malnutrition. Consequently, death results unless the patient undergoes corrective surgery (2) .
In the past, the standard treatment of patients with PMP was poorly defined. Many agree that PMP should be treated by aggressive local therapy ( i.e., total resection in gross), if safely feasible, at least in the initial operation (3) . Subsequent debulking operations usually focus on evacuating as much tumour tissue and ascites as possible. This approach has resulted in overall survival figures of 21% to 32% after ten years of follow-up (4) (5) (6) .
INTRODUCTION
Pseudomyxoma peritonei (PMP) is a rare clinical entity affecting one to two persons per million annually (1) . It is characterised by the peritoneal deposition of
The new treatment protocol consisting of aggressive cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has a curative intent (7) . The principles of CRS and HIPEC are described by Paul H. Sugarbaker in detail elsewhere (8) (9) . A combination of CRS and HIPEC has resulted in overall survival figures of over 50% after ten years of follow-up (10) (11) (12) (13) .
Our present study was designed to analyse the symptoms, signs and diagnostic examinations, as well as the indications for surgery of patients with PMP. Because the new treatment protocol seems to prolong the survival of patients with PMP, patients with PMP would presumably benefit from early diagnosis. Our retrospective analysis over a 25-year period will further characterise the manifestations of PMP.
MATERIAL AND METHODS
From June 1984 to September 2009, a consecutive series of 82 patients with histologically confirmed PMP of appendiceal origin were treated at the Helsinki University Central Hospital. A retrospective chart review was performed of all known PMP cases at our unit throughout the 25-year period. The cases were reviewed regardless of the treatment strategy. No further classification into the pathological subgroups was made, but all patients with PMP were included (14) . Of the 82 cases treated in our unit, 19 (23%) were diagnosed in our unit and 63 (77%) in referring units. All patients underwent either initial or subsequent surgery at the Helsinki University Central Hospital. We were able to obtain the complete medical and surgical records from both our unit and the referring units. Of the 82 initial surgeries, 23 (28%) were performed with a suspicion or diagnosis of PMP.
We analysed the patients' characteristics, indications for surgery and preoperative radiological investigations. No preoperative serum tumour marker levels were analysed as the measurement pattern in this patient population was not standardised. Of the 82 patients, 54 (66%) underwent initial surgery without CEA and CA19-9 measurements.
Serial debulking has been the traditional protocol at the Helsinki University Central Hospital for managing patients with PMP. Since 2007, aggressive cytoreductive surgery (CRS) using peritonectomy procedures followed by HIPEC has also been used in selected patients. The outcomes for patients with PMP treated by serial debulking have been reported elsewhere (4).
All analyses were performed using SPSS® for Windows 16.0.1 software (SPSS Inc, Chicago, IL, USA, 2007). The sex preponderance was analysed with the chi-square method. The data were presented in proportions (percentages) for categorical variables, and as means ± standard errors (medians) for continuous variables.
RESULTS
This study comprised 82 patients with PMP of appendiceal origin, 53 of whom were women (65%) and 29, men (35%). Their mean age at the time of diagnosis was 52.3 ± 1.4 years (median 52, range 25-87). The preponderance of women was statistically significant (p = 0.008).
The patients could be classified into six groups based on their clinical presentation at the first appointment. The chief complaint, which was the onset of their medical evaluation, was the denominator of each group. The chief complaint was inevitably not the only symptom, but did constitute the reason for obtaining a medical examination. The distribution results, also analysed according to gender, as well as the chief complaints in groups one to four, appear in Table 1 . The fifth group consisted of ten women and a man whose diagnosis of PMP was simply coincidental. Routine gynaecological examination was the onset of a medical course in six women. Gravidity, infertility examination, traumatic genital wound and trauma CT-scan were individual circumstances leading to the discovery of PMP in four women and symptoms of prostatitis in a single man. The sixth group consisted of nine women and two men who could not be classified in any other groups. Three women suffered dysmenorrhea and two pollacisuria. Individiual reasons for four women were cystocoele, fever, mucoid faeces and palpable tumour and for two men were hydrocoele and palpable tumour.
The histopathological diagnosis of PMP was assessed using open surgical biopsy taken at the initial surgery in 70 cases (85%), at the 2 nd -look operation in 7 cases (9%), and at 3 rd look operation in 1 case. Three patients (4%) had a definitive histopathological diagnosis of PMP prior to initial surgery, as the samples were acquired with ultrasonography-assisted transabdominal gross needle biopsy. A single case of PMP was diagnosed with ultrasonography-assisted transadbominal gross needle biopsy after initial surgery due to the presence of a funicular tumor. Misdiagnoses after six initial surgeries and one subsequent surgery appear in Table 2 . Of those 23 initial surgeries, 6 were performed since 2007 in full readiness for a combined therapy of CRS and HIPEC.
Various methods were used to perform radiological investigation for the patient population. Of the 82 patients, 35 (43%) underwent computed tomography prior to initial surgery, 65 (79%) were investigated with ultrasonography, 3 patients (4%) with magnetic resonance imaging and 1 patient (1%) with gastrointestinal contrast film. PMP was identified in 18 (51%) of aforementioned 35 CT scans. Of the 23 patients who underwent initial surgery with a suspicion or diagnosis of PMP, the diagnosis was first suggested by computed tomography in seven patients (30%), by ultrasonography in eight patients (35%), by magnetic resonance imaging in one patient (4%), by a combination of ultrasonography-assisted fine needle biopsy and gastrointestinal contrast film in one patient (4%), by ultrasonography-assisted fine needle biopsy in three patients (13%), and three patients (13%) had received a definitive preoperative diagnosis, as mentioned previously. Of the 23 patients diagnosed preoperatively with PMP or who underwent laparotomy with a preoperative suspicion of PMP, 18 (78%) were investigated with computed tomography preceding initial surgery. All those 18 patients produced typical radiological findings for PMP, as reported elsewhere (15) , although in 11 cases the CT scan was not the first investigation to suggest such a diagnosis. Suspected ovarian tumour was the most common cause for surgery, overall comprising 26 of 82 initial surgeries (32%). When analysed by sex, presumed PMP constituted the most common cause for surgery among men, with 45% of men receiving a diagnosis of PMP while undergoing surgery with the correct hypothesis. Suspected ovarian tumour constituted the most common reason for surgery among women. Of women in our study, 49% had their diagnoses established by those surgeries. The distribution of presumed preoperative diagnoses in full extent, also analysed by sex, appear in Table 3 .
DISCUSSION
The present study noted the significant preponderance of women. A similar effect has also been reported previously (1, 5) . However, because no sexrelated risks for neoplasms of colorectal origin are currently known, it is improbable that female preponderance has a known biological explanation. Rather, the effect is more likely the result of some referral bias, possibly due to the use of iterative surgery in secondary care hospitals to treat male patients with PMP and not referring them to a tertiary unit; female patients were more likely to be referred due to pre- The pathological sampling was not performed in three initial surgeries and one subsequent surgery. The histopathological diagnosis was incorrect in three initial surgeries. sumed ovarian malignancy requiring complex procedures available only in tertiary care units. Indeed, gynecologists seem to hold key position in making the primary diagnosis of PMP in women. Among our patients, 26 of 53 women (49%) underwent the initial operation because of a suspicion of ovarian tumour, and 6 of 53 (11%) received as a coincidental diagnosis of PMP during a routine gynecological examination. The misdiagnosis of PMP for ovarian tumour is understandable considering the close proximity of the appendix to the right ovary and the fact that ovaries are often affected by PMP. In addition, the diagnosis of ovarian tumour leading to gynecological laparotomy or laparoscopy is still based mainly on clinical examination and vaginal ultrasound. Computed tomography is seldom performed prior to surgical exploration. Therefore, if gynecological tumour markers are negative, we recommend further investigation with computed tomography as well as CEA and CA 19-9 measurements to avoid nonradical primary surgery (2, 15, 16) . Even if computed tomography confers far-from-optimal sensitivity in showing the thin peritoneal PMP layer, often leading to preoperative underestimation of the true tumour load, it is nevertheless the best diagnostic method currently available (2, 15) . In the present study, CT had a sensitivity of 51% in identifying PMP.
As shown previously (17), symptoms of appendicitis as the first presentation of PMP are common, occurring in 9% of our patient population. Undoubtedly, differential diagnosis between the perforated and inflamed mucocele and normal appendicitis may often be difficult, especially for young surgeons performing appendectomies while on duty. For that reason, performing routine histological examinations of ectomised appendices is important. Mostly, such cases that mimick the manifestation of appendicitis remain restricted, and thus favourable for CRS and HIPEC.
Obviously, not all cases are suitable for CRS and HIPEC. Still, there is increasing evidence proposing that combined treatment should be considered as the treatment of choice in selected patients (18) . Also, the reported variable rate of perioperative mortality between 0% and 18% and morbidity between 30% and 70% should be deemed acceptable if the risk factors related to this treatment regime are awared and carefulness in patient selection is emphasized (19, 20) . Because of the extreme rarity of PMP and the complex nature of CRS and HIPEC, it is distinct that the treatment should be performed only in specialised centers (18) . Only in such center it is possible to evaluate the patients feasible for this combined therapy.
In conclusion, only 28% of our patient population underwent initial surgery for presumed PMP. Only six patients underwent initial surgery in full readiness for CRS and HIPEC, because no treatment protocol was available until 2007. The accuracy of diagnostics prior to initial surgery cannot be considered good. We would recommend a more careful patient investigation prior to initial surgery, when possible, and close co-work between colorectal surgeons and gynaecologists to increase the awareness of PMP.
